Home › Funds › GordonMD Global Investments LP › ALLO
GordonMD Global Investments LP position in ALLO
ALLOGENE THERAPEUTICS INC · Health Care
GordonMD Global Investments LP reported holding 5,298,000 shares of ALLO (ALLOGENE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$8.5M, representing 5.09% of its reported portfolio and ranking #8 among its reported holdings. GordonMD Global Investments LP has disclosed ALLO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GordonMD Global Investments LP's ALLO position evolved
GordonMD Global Investments LP first disclosed a stake in ALLO in Q1 2026 at 1,430,000 shares (US$3.5M). The position peaked in Q2 2026 at 5,298,000 shares, worth US$11.0M. Across 3 filings, GordonMD Global Investments LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 5,298,000 shares valued at US$8.5M. Notable position changes include a 270% increase in Q2 2026 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.43M | $3.49M | New |
| Q2 2026 | 5.30M | $11.02M | Add |
| Q3 2026 | 5.30M | $8.48M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALLO and 13F data
ALLO (ALLOGENE THERAPEUTICS INC) is a Health Care company. 37 other funds we track also report a position in ALLO — the largest reported positions include Frazier Life Sciences Management, L.P. (US$46.7M), TPG GP A, LLC (US$38.9M), PFIZER INC (US$36.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALLO
- Frazier Life Sciences Management, L.P. 22.45M sh · $46.69M · Q2 2026
- TPG GP A, LLC 18.72M sh · $38.93M · Q2 2026
- PFIZER INC 22.03M sh · $36.35M · Q3 2026
- Sio Capital Management, LLC 9.10M sh · $14.57M · Q3 2026
- Patient Square Capital LP 4.55M sh · $7.28M · Q3 2026
- Wildcat Capital Management, LLC 2.92M sh · $4.67M · Q3 2026
- DAFNA Capital Management LLC 2.00M sh · $4.16M · Q2 2026
More on GordonMD Global Investments LP
FAQ
How long has GordonMD Global Investments LP held ALLO?
GordonMD Global Investments LP has disclosed ALLO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is GordonMD Global Investments LP's current position in ALLO?
As of Q3 2026, GordonMD Global Investments LP holds 5.30M shares of ALLO (ALLOGENE THERAPEUTICS INC), valued at $8.48M, representing 5.09% of its reported portfolio and ranking #8.
Has GordonMD Global Investments LP been buying or selling ALLO?
In the latest 13F filing (Q3 2026), GordonMD Global Investments LP held unchanged its position in ALLO. The position peaked in Q2 2026 at 5.30M shares.
Which other funds hold ALLO?
Other major institutional holders of ALLO include Frazier Life Sciences Management, L.P., TPG GP A, LLC, PFIZER INC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.